News

Home
Manufacturing
Manufacturing
OEM Manufacturing
Quality Control
About the Factory
About the Factory
Our History
Management
Certificates
Partners
Licenses
Achievements
Special Evaluation of Labour Conditions
Videos
News
Products
Contacts
Contacts
Quality Claims

News

Details: Published: 10 September 2013

YEKATERINBURG. Bayer, the German corporation, and Medsintez, the Novouralsk plant, have agreed on joint drug manufacturing.

Details: Published: 06 September 2013

On September 9, Medsintez, the Novouralsk plant, will release its first lot of the Aveloks antibiotic. As Alexander Petrov (Jr.), Chairman of Medsintez's Board of Directors, told the EAN agency, the manufacturing of this new-generation drug is carried out according to the agreement signed with the plant's strategic partner, Bayer (Germany).

Details: Published: 20 August 2013

In Q4 2013, the Medsintez plant, for the first time in Russia, will begin to produce disposable insulin syringe pens for patients with diabetes mellitus. The price of a set of five pens will be approximately 600-700 roubles; a similar set from a foreign manufacturer costs 800 roubles. On prescription, residents of the Sverdlovsk region will be able to get them for free.

Details: Published: 02 November 2012

"The signed strategic agreement includes the results of months of collaboration between the two companies.

Details: Published: 02 November 2012

In 2013, Bayer (the Russian division of Bayer AG) will launch the drug production on the premises of Medsintez, an Ural plant, as Alexander Petrov, Chairman of Medsintez's Board of Directors has told.